Search
for
Sort by
Research 451–480 of 1000+
- JAK inhibitors for the treatment of alopecia areata
- A clinical analysis of 304 cases with alopecia areata in children
- [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)].
- Novel investigational drugs for alopecia areata and future perspectives
- Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients
- Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin
- Dermoscopy of alopecia areata in restrospective analysis
- Supplementary file 1_Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.docx
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Desideratum dermatologica – wanted: a dependable and safe means to prevent alopecia areata progression to the totalis/universalis state
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Table 1_Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata.docx
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Clinical presentation and dermoscopic features of alopecia areata patients
- Clinical Correlation Between Alopecia Areata and Salmon Patches: A Case Series
- Refractory Myasthenia Gravis and Concurrent Alopecia Areata Postthymectomy With Improvements After Cortisone Taper: A Case Report
- Alopecia areata and primary sclerosing cholangitis
- A PUVA-turban as therapeutical option in the management of alopecia areata
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- JAK Inhibitors for Treatment of Alopecia Areata
- Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
- Alopecia areata: Part 2: treatment.
- Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- European expert consensus statement on the systemic treatment of alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review